Statistical analysis involving the identification of risk factors in patients with lung cancer
Keywords:
involved statistical analysis, lung cancer, risk factor, logistical regression, sensibility, specificity, secondary health care.Abstract
An analytic study of cases and controls was carried out, in order to evaluate the usefulness of the statistical analysis involved in the identification of risk factors in patients with lung neoplasia, assisted in "Conrado Benítez García" and "Dr. Juan Bruno Zayas Alfonso" hospitals in Santiago de Cuba, from July 1st, 2012 to June 31st, 2013. Fifty cases were selected by means of a random systematic sampling and the same quantity of controls according to sampling through conglomerates in 4 stages (1:1). Logistical regression techniques and the statistical analysis were compared; the first one was used as keystone and sensibility, specificity, reasons of verisimilitude and index of Kappa were obtained, between them. It is concluded that both techniques are supplemented in the identification of risk factors and they allow a more complete interpretation of the causality phenomenon.
Downloads
References
2. Molina E, Barceló C, Bonito LA, Del Puerto C. Factores de riesgo de cáncer pulmonar en Ciudad de La Habana. Rev Cubana Hig Epidemiol. 1996 [citado 8 Dic 2014]; 34(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-30031996000200002
3. Lorenzo-Luaces P, Galán Y, Abascal ME. Técnicas estadísticas multivariadas en la investigación epidemiológica. Ejemplo en la prevalencia de factores de riesgo de cáncer en Cuba. Rev Cubana Oncol. 1995 [citado 8 Dic 2014]; 11(1). Disponible en: http://www.bvs.sld.cu/revistas/onc/vol11_1_95/onc12195.htm
4. Hair JF, Anderson RE, Tatham RL, Black WC. Introducción. Tipos de técnicas multivariantes. En: Otero A. Análisis multivariante. Madrid: Prentice Hall Iberia; 1999. p.11.
5. Chitarroni H. La regresión logística. Buenos Aires: IDICSO; 2002.
6. Orús P, Zamora L, Gregori P. El Análisis Estadístico Implicativo (ASI) en respuesta a problemas que le dieron origen. En: Teoría y aplicaciones del Análisis Estadístico Implicativo: primera aproximación en lengua hispana. Castellón: Departamento de Matemática de la Universitat Jaume I; 2009. p. 3-51.
7. Orús P, Zamora L, Gregori P. Conceptos fundamentales del Análisis Estadístico Implicativo (ASI) y su soporte computacional CHIC. En: Teoría y aplicaciones del Análisis Estadístico Implicativo: primera aproximación en lengua hispana. Castellón: Departamento de Matemática de la Universitat Jaume I; 2009. p. 65-103.
8. Caicoya M, Mirón JA. Cáncer de pulmón y tabaco en Asturias. Un estudio de casos y controles. Gac Sanit. 2003 [citado 15 Mar 2015]; 17(3). Disponible en: http://scielo.isciii.es/scielo.php?pid=S0213-91112003000300009&script=sci_arttext&tlng=e
9. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest. 2004; 125(1):27–37.
10. Gorlova OY, Weng SF, Zhang Y, Amos CI, Spitz MR. Aggregation of cancer among relatives of never-smoking lung cancer patients. IJC. 2007;121(1):111–8.
11. Kumar V, Cotran RS, Robbins S. Cáncer de pulmón. En: Patología humana. 7 ed. España: Elsevier; 2008. p. 500.
12. Senra A. El cáncer: epidemiología, etiología, diagnóstico y prevención. Madrid: Ediciones Harcourt; 2002.
13. Catelinois O, Rogel A, Laurier D, Billon S, Hemon D, Verger P, et al. Lung cancer attributable to indoor radon exposure in France: impact of the risk models and uncertainty analysis. Environ Health Perspec. 2006; 114(9):1361–6.
14. Speizer FE. Perspectiva general del riesgo de cáncer respiratorio por contaminantes atmosféricos. En: Curso básico sobre contaminación del aire y riesgos para la salud. Metepec: ECO/OPS/OMS; 1991. p. 268-86.
15. Bakris GL, Mulopulos GP, Korchik R, Ezdinli EZ, Ro J, Yoon BH. Pulmonary scar carcinoma. A clinicopathologic analysis. Cancer. 1983; 52(3):493-7.
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.